CIK 0001553643
- Non-accelerated filer
- Smaller reporting company
RELMADA THERAPEUTICS, INC.
Sign in to watch- Ticker
- RLMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 455401931
- Phone
- +1 646-876-3459
- Business address
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, CORAL GABLES, FL, 33134
- Former names
- CAMP NINE, INC.
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Operating Officer bought 200,000 shares at $0.43 ($86,060)
- 4 Open-market buy Chief Financial Officer bought 200,000 shares at an average $0.49 ($97,208)
- 4 Open-market buy CA and CO bought 228,961 shares at $0.45 ($103,330)
- 4 Open-market buy Chief Executive Officer bought 350,000 shares at an average $0.50 ($174,713)
- 4 Gift Director gave 13,000 shares (gift)
- 4 Open-market buy Chief Executive Officer bought 140,000 shares at an average $2.82 ($395,115)
- 4 Open-market buy Director bought 13,000 shares at $2.56 ($33,280)
- 4 Open-market buy Chief Financial Officer bought 53,432 shares at an average $2.80 ($149,701)
- 4 Open-market buy Director bought 25,000 shares at $2.59 ($64,750)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Executive Officer bought 100,000 shares at an average $3.87 ($386,738)
- 4 Open-market buy Chief Financial Officer bought 32,675 shares at an average $3.85 ($125,717)
- 4 Open-market buy CA and CO bought 38,970 shares at an average $3.87 ($150,920)
Page 2 of 10 · 200 filings